Duncker Streett & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $624K | Sell |
679
-11
| -2% | -$11.2K | 0.12% | 143 |
|
|
2025
Q4 | $742K | Sell |
690
-82
| -11% | -$78.4K | 0.13% | 120 |
|
|
2025
Q3 | $589K | Buy |
772
+11
| +1% | +$8.19K | 0.1% | 138 |
|
|
2025
Q2 | $593K | Hold |
761
| – | – | 0.11% | 144 |
|
|
2025
Q1 | $628K | Sell |
761
-99
| -12% | -$82.4K | 0.12% | 132 |
|
|
2024
Q4 | $664K | Sell |
860
-39
| -4% | -$32.3K | 0.12% | 130 |
|
|
2024
Q3 | $797K | Buy |
899
+7
| +0.8% | +$6.29K | 0.15% | 123 |
|
|
2024
Q2 | $808K | Hold |
892
| – | – | 0.16% | 119 |
|
|
2024
Q1 | $694K | Buy |
892
+202
| +29% | +$144K | 0.14% | 129 |
|
|
2023
Q4 | $402K | Buy |
690
+1
| +0.1% | +$584 | 0.08% | 166 |
|
|
2023
Q3 | $370K | Hold |
689
| – | – | 0.09% | 160 |
|
|
2023
Q2 | $323K | Sell |
689
-18
| -3% | -$7.55K | 0.07% | 182 |
|
|
2023
Q1 | $243K | Hold |
707
| – | – | 0.06% | 190 |
|
|
2022
Q4 | $259K | Hold |
707
| – | – | 0.06% | 190 |
|
|
2022
Q3 | $229K | Hold |
707
| – | – | 0.06% | 196 |
|
|
2022
Q2 | $229K | Hold |
707
| – | – | 0.05% | 207 |
|
|
2022
Q1 | $202K | Buy |
707
+1
| +0.1% | +$257 | 0.04% | 228 |
|
|
2021
Q4 | $195K | Sell |
706
-183
| -21% | -$46.4K | 0.03% | 245 |
|
|
2021
Q3 | $205K | Sell |
889
-389
| -30% | -$96K | 0.04% | 232 |
|
|
2021
Q2 | $293K | Hold |
1,278
| – | – | 0.05% | 208 |
|
|
2021
Q1 | $239K | Sell |
1,278
-200
| -14% | -$39.1K | 0.05% | 223 |
|
|
2020
Q4 | $249K | Sell |
1,478
-559
| -27% | -$83.5K | 0.05% | 215 |
|
|
2020
Q3 | $302K | Buy |
2,037
+300
| +17% | +$46.4K | 0.07% | 198 |
|
|
2020
Q2 | $285K | Sell |
1,737
-249
| -13% | -$38.2K | 0.07% | 197 |
|
|
2020
Q1 | $276K | Buy |
1,986
+1
| +0.1% | +$137 | 0.07% | 203 |
|
|
2019
Q4 | $261K | Hold |
1,985
| – | – | 0.05% | 233 |
|
|
2019
Q3 | $222K | Buy |
1,985
+1
| +0.1% | +$111 | 0.05% | 242 |
|
|
2019
Q2 | $220K | Sell |
1,984
-400
| -17% | -$47.1K | 0.05% | 246 |
|
|
2019
Q1 | $309K | Buy |
2,384
+401
| +20% | +$48.8K | 0.07% | 224 |
|
|
2018
Q4 | $230K | Hold |
1,983
| – | – | 0.06% | 230 |
|
|
2018
Q3 | $213K | Buy |
1,983
+1
| +0.1% | +$100 | 0.05% | 256 |
|
|
2018
Q2 | $169K | Hold |
1,982
| – | – | 0.04% | 269 |
|
|
2018
Q1 | $153K | Buy |
1,982
+1
| +0.1% | +$81 | 0.04% | 276 |
|
|
2017
Q4 | $167K | Buy |
1,981
+1
| +0.1% | +$85 | 0.04% | 273 |
|
|
2017
Q3 | $169K | Hold |
1,980
| – | – | 0.05% | 258 |
|
|
2017
Q2 | $163K | Buy |
1,980
+1
| +0.1% | +$82 | 0.05% | 261 |
|
|
2017
Q1 | $166K | Hold |
1,979
| – | – | 0.05% | 261 |
|
|
2016
Q4 | $146K | Buy |
1,979
+1
| +0.1% | +$74 | 0.05% | 267 |
|
|
2016
Q3 | $159K | Buy |
1,978
+184
| +10% | +$14.7K | 0.06% | 253 |
|
|
2016
Q2 | $141K | Hold |
1,794
| – | – | 0.05% | 257 |
|
|
2016
Q1 | $129K | Sell |
1,794
-464
| -21% | -$35.1K | 0.05% | 259 |
|
|
2015
Q4 | $190K | Buy |
2,258
+1
| +0% | +$83 | 0.07% | 233 |
|
|
2015
Q3 | $189K | Hold |
2,257
| – | – | 0.07% | 238 |
|
|
2015
Q2 | $188K | Buy |
2,257
+1
| +0% | +$76 | 0.07% | 248 |
|
|
2015
Q1 | $164K | Hold |
2,256
| – | – | 0.05% | 258 |
|
|
2014
Q4 | $156K | Buy |
2,256
+1
| +0% | +$67 | 0.05% | 268 |
|
|
2014
Q3 | $146K | Buy |
2,255
+165
| +8% | +$10.4K | 0.05% | 271 |
|
|
2014
Q2 | $130K | Buy |
2,090
+390
| +23% | +$23.3K | 0.04% | 302 |
|
|
2014
Q1 | $100K | Sell |
1,700
-1,556
| -48% | -$86.8K | 0.04% | 307 |
|
|
2013
Q4 | $166K | Buy |
3,256
+700
| +27% | +$35.1K | 0.06% | 256 |
|
|
2013
Q3 | $129K | Hold |
2,556
| – | – | 0.05% | 264 |
|
|
2013
Q2 | $126K | Buy |
+2,556
| New | +$139K | 0.05% | 273 |
|
Other funds holding LLY
VCM
VPM
Duncker Streett & Co's LLY Position: Q1 2026 in Review
Duncker Streett & Co reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $11.2K and leaving 679 shares worth $624K. The position accounts for 0.12% of the portfolio, ranked #143.
Duncker Streett & Co first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $808K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Duncker Streett & Co held 679 shares of Eli Lilly worth $624K as of Q1 2026.
- Duncker Streett & Co sold 11 Eli Lilly shares in Q1 2026, an estimated $11.2K.
- Eli Lilly made up 0.12% of Duncker Streett & Co's portfolio in Q1 2026, its #143 holding.
- Duncker Streett & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Duncker Streett & Co's Eli Lilly position peaked at $808K in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.